Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.34 |
| ▸ | MME | P08473 | 2/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | GPR139 | Q6DWJ6 | 2/20 | 0.31 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23589772 | 0.84 | MME (0.34) | F2TGFBR1MMEPSMB5 | |
| SCHEMBL865121 | 0.83 | TGFBR1 (0.52) | F2TGFBR1MMEKDM4E | |
| SCHEMBL865120 | 0.83 | TGFBR1 (0.52) | F2TGFBR1MMEKDM4E | |
| SCHEMBL19142250 | 0.81 | F2 (0.38) | F2PSMB5KDM4EMAPK1HIF1A | |
| SCHEMBL25603596 | 0.79 | TGFBR1 (0.37) | TGFBR1MME | |
| SCHEMBL1909473 | 0.75 | MAPT (0.48) | TGFBR1KDM4E | |
| SCHEMBL15826905 | 0.75 | MAPT (0.48) | TGFBR1KDM4E | |
| SCHEMBL13961927 | 0.74 | CYP2C9 (0.45) | TGFBR1MMEPSMB5POLB | |
| SCHEMBL23080527 | 0.74 | CYP2C9 (0.45) | TGFBR1MMEPSMB5POLB | |
| SCHEMBL16093456 | 0.74 | FOLH1 (0.50) | F2KDM4EMAPK1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024054870-A1 | USE OF IL-7R-ALPHA-GAMMA AGONIST PEPTIDES IN CELL MANUFACTURING | MEDIKINE, INC. (US) | 2024-03-14 | — | — | WO | disclosed |